Osteoprotegerin and Mortality in Type 2 Diabetic Patients

OBJECTIVE: Plasma osteoprotegerin (OPG) is an emerging strong and independent predictor of cardiovascular disease (CVD) in high-risk populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells, and increased plasma OPG levels may reflect arterial vascular damage. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhard, Henrik, Lajer, Maria, Gall, Mari-Anne, Tarnow, Lise, Parving, Hans-Henrik, Rasmussen, Lars M., Rossing, Peter
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992191/
https://www.ncbi.nlm.nih.gov/pubmed/20929997
http://dx.doi.org/10.2337/dc10-0858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992191/
https://www.ncbi.nlm.nih.gov/pubmed/20929997
http://dx.doi.org/10.2337/dc10-0858

Ejemplares similares